On June 11, 2014, the FDA announced the availability of a draft guidance entitled “Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification.” The draft guidance clarifies for trading partners certain new requirements in the Federal Food, Drug, and Cosmetic Act, as amended by the Drug Supply Chain Security Act (DSCSA). The
More Posts
Major FDA Announcement on OTCs
FDA Seeks Comments on Proposal to Make De-Identified and Masked Data from Product Applications Available for Use by Outside Experts and Other Interested Parties
A Press Release Cautionary Tale: Harkonen Conviction Upheld
Free speech mandates vacating off-label promotion conviction, says Second Circuit in United States v. Caronia
Updates from FDLI’s Advertising & Promotion Conference and the Pharmaceutical & Regulatory Compliance Congress
Hogan Lovells Comments on the FDA’s “Draft Guidance on Responding to Unsolicited Requests”
Subscribe: Subscribe via RSS
Blogs
Firm/Org